Fortrea FTRE
Fortrea Holdings Inc. · Nasdaq · Services-Medical Laboratories
$25.88+5.94%close on Oct. 28, 2026 · volume 3.6M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Sept. 9, 2026 | Carrie Elizabeth Russell Interim CAO | Sold | 246 | $16.85 | $4,145 |
| Sept. 9, 2026 | Mark A. Morais Chief Operating Officer | Sold | 3,149 | $16.85 | $53,061 |
| Aug. 19, 2026 | Mark A. Morais Chief Operating Officer | Sold | 4,892 | $18.19 | $88,985 |
| Aug. 6, 2026 | Anshul Thakral Chief Executive Officer, director | Sold | 111,857 | $18.11 $18.06-$18.17 | $2.03 million |
| Aug. 5, 2026 | Anshul Thakral Chief Executive Officer, director | Sold | 99,869 | $19.16 $19.03-$19.28 | $1.91 million |
| Aug. 3, 2026 | Machelle Sanders director | Sold | 9,700 | $18.01 | $174,697 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 13 →Departure/appointment of directors or officers
Departure/appointment of directors or officers